Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-21

Clinical Trial Update: Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia [NA]

View source ↗

Summary

Clinical trial update on radiofrequency ablation for esophageal squamous cell neoplasia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: Covidien, GI Solutions | Conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA | NA | Status: COMPLETED | Results posted: 2020-05-21